Open Access · CC BY-NC 3.0
Key feasibility considerations when conducting vaccine clinical trials in Asia–Pacific countries
Vaccine: Development and Therapy · 2013
DOI: 10.2147/vdt.s41903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccine: Development and Therapy, 2013. Verfasst von Lansang und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lansang, Tan, Nayak, S., Lee, & Wai, K. (2013). Key feasibility considerations when conducting vaccine clinical trials in Asia–Pacific countries. Vaccine: Development and Therapy. https://doi.org/10.2147/vdt.s41903
Vancouver
Lansang, Tan, Nayak S, Lee, Wai K. Key feasibility considerations when conducting vaccine clinical trials in Asia–Pacific countries. Vaccine: Development and Therapy. 2013. doi:10.2147/vdt.s41903
BibTeX
@article{Lansang2013,
author = {Lansang and Tan and Nayak, Saumya and Lee and Wai, Karen},
title = {Key feasibility considerations when conducting vaccine clinical trials in Asia–Pacific countries},
journal = {Vaccine: Development and Therapy},
year = {2013},
doi = {10.2147/vdt.s41903}
}
EUVIMED